Background: Alzheimer's disease (AD) substantially increases health-related costs. This study investigates direct medical costs and characterizes the caregiver burden across AD stages.
Methods: This study analyzed data from the French Primary Health Insurance Fund claims database and reflected this public payer perspective.
Introduction: Published estimates of Alzheimer's disease (AD) progression do not capture the full disease continuum. This study provides transition probabilities of individuals with amyloid-β (Aβ+) pathology across the disease continuum.
Methods: Patient-level longitudinal data from the National Alzheimer's Coordinating Center were used to estimate progression rates.